Insights

Clinical-stage niche XEME Biopharma is a clinical-stage biotechnology company focused on active cancer immunotherapy vaccines, presenting a target for partnerships or collaborations with larger pharma players seeking early-stage assets with potential for rapid advancement.

Innovative platforms The Aggregon and Oncolipin platforms enable personalized autologous vaccines as well as off-the-shelf options, suggesting opportunities to co-develop or license complementary technologies, manufacturing capabilities, or regulatory pathways with vaccine-focused partners.

Rapid manufacturing With a claimed manufacturing time under 24 hours and low per-dose costs, there is a compelling value proposition for cost-conscious health systems and potential partners to pursue scalable production arrangements or contract manufacturing opportunities.

Financial footprint Current revenue is under one million dollars and the company has a very small headcount, implying a need for strategic partnerships, licensing deals, or venture-backed partnerships to accelerate development and go-to-market plans.

Market positioning Positioned in the cancer vaccines space as a disruptive, potentially high-margin platform with broad clinical applications, presenting selling points for big pharma to bolster immunotherapy portfolios, especially in leukemia and lymphoma indications.

Similar companies to XEME Biopharma Inc.

XEME Biopharma Inc. Tech Stack

XEME Biopharma Inc. uses 8 technology products and services including Wix, WordPress, Webpack, and more. Explore XEME Biopharma Inc.'s tech stack below.

  • Content Management System
  • Content Management System
  • Webpack
    Development
  • E-commerce
  • Infrastructure As A Service
  • Issue Trackers
  • WordPress.com
    Platform As A Service
  • HTTP/3
    Web & Portal Technology

XEME Biopharma Inc.'s Email Address Formats

XEME Biopharma Inc. uses at least 1 email format:
XEME Biopharma Inc. Email FormatsExamplePercentage
FLast@xemebiopharma.comJDoe@xemebiopharma.com
100%

Frequently Asked Questions

What is XEME Biopharma Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact XEME Biopharma Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is XEME Biopharma Inc.'s official website and social media links?

Minus sign iconPlus sign icon
XEME Biopharma Inc.'s official website is xemebiopharma.com and has social profiles on LinkedIn.

How much revenue does XEME Biopharma Inc. generate?

Minus sign iconPlus sign icon
As of November 2026, XEME Biopharma Inc.'s annual revenue is estimated to be <$1M.

What is XEME Biopharma Inc.'s SIC code and NAICS code?

Minus sign iconPlus sign icon
XEME Biopharma Inc.'s SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does XEME Biopharma Inc. have currently?

Minus sign iconPlus sign icon
As of November 2026, XEME Biopharma Inc. has approximately 3 employees across 1 continents, including North America. Key team members include President: M. P., President: M. P. and Chairman: M. T. Explore XEME Biopharma Inc.'s employee directory with LeadIQ.

What industry does XEME Biopharma Inc. belong to?

Minus sign iconPlus sign icon
XEME Biopharma Inc. operates in the Biotechnology Research industry.

What technology does XEME Biopharma Inc. use?

Minus sign iconPlus sign icon
XEME Biopharma Inc.'s tech stack includes Wix, WordPress, Webpack, Wix eCommerce, Google Cloud, Sentry, WordPress.com and HTTP/3.

What is XEME Biopharma Inc.'s email format?

Minus sign iconPlus sign icon
XEME Biopharma Inc.'s email format typically follows the pattern of FLast@xemebiopharma.com. Find more XEME Biopharma Inc. email formats with LeadIQ.

When was XEME Biopharma Inc. founded?

Minus sign iconPlus sign icon
XEME Biopharma Inc. was founded in 2005.
XEME Biopharma Inc. logo

XEME Biopharma Inc.

Biotechnology ResearchNew Jersey, United States2-10 Employees

XEME Biopharma Inc. is a clinical-stage biotechnology company focused on developing vaccines for active cancer immunotherapy, aiming to shift cancer treatment beyond traditional options such as surgery, radiation, chemotherapy, and passive immunotherapy. The firm is based in Monmouth Junction, New Jersey, and operates with a small team. Its work centers on personalized autologous vaccines intended for leukemia and lymphoma.

Section iconCompany Overview

Phone number
SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2005
Employees
2-10

Section iconFunding & Financials

  • <$1M

    XEME Biopharma Inc.'s revenue is estimated to be in the range of <$1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.